Optimind Pharma Corp.
OMND
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -663.90K | -733.80K | -811.20K | -1.04M | -1.98M |
| Total Depreciation and Amortization | 0.00 | 3.70K | 9.30K | 14.80K | 22.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 426.30K | 432.80K | 454.50K | 595.60K | 1.53M |
| Change in Net Operating Assets | 92.40K | 137.90K | 263.80K | 77.20K | -34.00K |
| Cash from Operations | -145.20K | -159.40K | -83.60K | -349.50K | -465.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.00 | -11.60K | -13.90K | -16.80K | -64.80K |
| Cash from Investing | -200.00 | -11.60K | -13.90K | -16.80K | -64.80K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | 0.00 | -7.60K | -19.00K | -30.40K | -41.80K |
| Issuance of Common Stock | 270.00K | 270.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 197.20K | 191.60K | -14.20K | -22.60K | -31.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.80K | 20.60K | -111.50K | -388.80K | -560.80K |
